High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

OBJECTIVES: To evaluate risk factors associated with unfavourable outcomes: emergency care, hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in patients with immune-mediated rheumatic disease (IMRD) and COVID-19. METHODS: Analysis of the first 8 weeks of obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Claudia Diniz Lopes, Kakehasi, Adriana Maria, Pinheiro, Marcelo Medeiros, Mota, Licia Maria Henrique, Albuquerque, Cleandro Pires, Silva, Carolina Rocha, Santos, Gabriela Porfirio Jardim, Reis-Neto, Edgard Torres, Matos, Pedro, Devide, Guilherme, Dantas, Andrea, Giorgi, Rina Dalva, Omura, Felipe, Marinho, Adriana de Oliveira, Valadares, Lilian David Azevedo, Melo, Ana Karla G, Ribeiro, Francinne Machado, Ferreira, Gilda Aparecida, Santos, Flavia Patricia de Sena, Ribeiro, Sandra Lucia Euzebio, Andrade, Nicole Pamplona Bueno, Yazbek, Michel Alexandre, de Souza, Viviane Angelina, Paiva, Eduardo S, Azevedo, Valderilio Feijo, de Freitas, Ana Beatriz Santos Bacchiega, Provenza, José Roberto, de Toledo, Ricardo Acayaba, Fontenelle, Sheilla, Carneiro, Sueli, Xavier, Ricardo, Pileggi, Gecilmara Cristina Salviato, Reis, Ana Paula Monteiro Gomides
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844930/
https://www.ncbi.nlm.nih.gov/pubmed/33510041
http://dx.doi.org/10.1136/rmdopen-2020-001461
Descripción
Sumario:OBJECTIVES: To evaluate risk factors associated with unfavourable outcomes: emergency care, hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in patients with immune-mediated rheumatic disease (IMRD) and COVID-19. METHODS: Analysis of the first 8 weeks of observational multicentre prospective cohort study (ReumaCoV Brasil register). Patients with IMRD and COVID-19 according to the Ministry of Health criteria were classified as eligible for the study. RESULTS: 334 participants were enrolled, a majority of them women, with a median age of 45 years; systemic lupus erythematosus (32.9%) was the most frequent IMRD. Emergency care was required in 160 patients, 33.0% were hospitalised, 15.0% were admitted to the ICU and 10.5% underwent mechanical ventilation; 28 patients (8.4%) died. In the multivariate adjustment model for emergency care, diabetes (prevalence ratio, PR 1.38; 95% CI 1.11 to 1.73; p=0.004), kidney disease (PR 1.36; 95% CI 1.05 to 1.77; p=0.020), oral glucocorticoids (GC) (PR 1.49; 95% CI 1.21 to 1.85; p<0.001) and pulse therapy with methylprednisolone (PR 1.38; 95% CI 1.14 to 1.67; p=0.001) remained significant; for hospitalisation, age >50 years (PR 1.89; 95% CI 1.26 to 2.85; p=0.002), no use of tumour necrosis factor inhibitor (TNFi) (PR 2.51;95% CI 1.16 to 5.45; p=0.004) and methylprednisolone pulse therapy (PR 2.50; 95% CI 1.59 to 3.92; p<0.001); for ICU admission, oral GC (PR 2.24; 95% CI 1.36 to 3.71; p<0.001) and pulse therapy with methylprednisolone (PR 1.65; 95% CI 1.00 to 2.68; p<0.043); the two variables associated with death were pulse therapy with methylprednisolone or cyclophosphamide (PR 2.86; 95% CI 1.59 to 5.14; p<0.018). CONCLUSIONS: Age >50 years and immunosuppression with GC and cyclophosphamide were associated with unfavourable outcomes of COVID-19. Treatment with TNFi may have been protective, perhaps leading to the COVID-19 inflammatory process.

Ejemplares similares